These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1465035)

  • 21. Effects of synthetic progestational steroids on liver and serum lipids in rats.
    Uchida K; Nomura Y; Kadowaki M; Takeuchi N
    Endocrinol Jpn; 1976 Apr; 23(2):97-108. PubMed ID: 954685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study.
    Tiraş MB; Noyan V; Yildiz A; Yildirim M; Daya S
    Hum Reprod; 2000 Oct; 15(10):2087-92. PubMed ID: 11006178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of the ethynyl estrogens used in oral contraceptives. VII. Effects with and without progestational agents on ultracentrifugally fractionated plasma lipoproteins in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; de la Peña A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Nov; 30(5):522-33. PubMed ID: 214353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Time-dependent variations in bone turnover parameters during 2 months' cyclic treatment with different doses of combined estrogen and progestogen in postmenopausal women.
    Johansen JS; Jensen SB; Riis BJ; Christiansen C
    Metabolism; 1990 Nov; 39(11):1122-6. PubMed ID: 2233271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.
    Lindsay R; Gallagher JC; Kleerekoper M; Pickar JH
    JAMA; 2002 May 22-29; 287(20):2668-76. PubMed ID: 12020302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of various menopausal hormone therapies on markers of inflammation, coagulation, fibrinolysis, lipids, and lipoproteins in healthy postmenopausal women.
    Zegura B; Guzic-Salobir B; Sebestjen M; Keber I
    Menopause; 2006; 13(4):643-50. PubMed ID: 16837886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of two fixed hormonal replacement therapy protocols on blood lipid profile.
    Tadmor OP; Kleinman Y; Reisin A; Livshin Y; Diamant YZ
    Eur J Obstet Gynecol Reprod Biol; 1992 Sep; 46(2-3):109-16. PubMed ID: 1333421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of progestins in combined oral contraceptives on serum lipids with special reference to high-density lipoproteins.
    Wynn V; Niththyananthan R
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):766-71. PubMed ID: 6801982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
    Dane C; Dane B; Cetin A; Erginbas M
    Gynecol Endocrinol; 2007 Jul; 23(7):398-403. PubMed ID: 17701771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
    Bunyavejchevin S; Limpaphayom KK
    J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART study). A randomized controlled trial.
    Speroff L; Rowan J; Symons J; Genant H; Wilborn W
    JAMA; 1996 Nov; 276(17):1397-403. PubMed ID: 8892714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of 10 years' hormone replacement therapy on bone mineral content in postmenopausal women.
    Eiken P; Kolthoff N; Nielsen SP
    Bone; 1996 Nov; 19(5 Suppl):191S-193S. PubMed ID: 8922661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects on serum lipid profiles of continuous 17beta-estradiol, intermittent norgestimate regimens versus continuous combined 17beta-estradiol/norethisterone acetate hormone replacement therapy.
    Ylikorkala O; Lim P; Caubel P
    Clin Ther; 2000 May; 22(5):622-36. PubMed ID: 10868559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women.
    Cano A; Calaf J; Molina J
    Arch Gynecol Obstet; 2003 Oct; 268(4):317-22. PubMed ID: 14504877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal and metabolic effects of transdermal estradiol/progestagen administration in postmenopausal women.
    Perrone G; Falaschi P; Capri O; Pastore R; Galoppi P; D'Urso R; Martocchia A; Anelli G; Zichella L
    Int J Fertil Menopausal Stud; 1994; 39(4):202-7. PubMed ID: 7951402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women.
    Caird LE; Reid-Thomas V; Hannan WJ; Gow S; Glasier AF
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):739-45. PubMed ID: 7889609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.